Share This

Topics Comments
 < Previous page    Next page > 
Cheung Kong VODone Limited Shenzhen International Holdings Limited Jiangxi Copper Company Limited REXLot Holdings Limited China Overseas Land & Investment Limited Chong Hing Bank Limited Agricultural Bank of China Limited Chow Tai Fook Jewellery Group Limited Capital VC Limited iShares A50 Standard Chartered Bank of Communications Bank of China China LotSynergy Holdings Limited agribank Agri Airlines Appl AUD Auto A Shares Brokers CAD fertilizer producers China Lottery Supermarket China Banks Communication Consumer China Econ Electricity China Finance China IT Petro Real Est China Resource Steel coal Commodity Beauty Drugs Enviro EURO Lang Simon Ting WongSir Andy Xie Expo Gambling Garment gas GBD Gold Gold Jew Gold mine Harbour Highways HK Apparel REITs Rentals HK Banks ETF HK Housing Market Real Est HK HK Stock iBond Infra Insure IPO jewel Mach Build Mat New Energy NZD Oil Paper Rare Earths Real Estate Market Food RMB Rising RMB RMB Bonds Shipbuilding Shipping Sports Stock Trend Taiwan Dollar (TWD) Textile Top 500 USD US Econ Util Water Yang Liu's 10 Stocks YEN Diary media Central Bank Monetary Policy Education Construction Emerging markets Nuclear power BillGross Cement HK retail logistics Swiss franc Social Security Fund Law Ka-Chung capital flow Financial and political policy Railway film Korean Won Roubini Faber Mobius
Topics Last reply time Nickname Content
Alibaba Health Information Technology Limited 2021-08-20T14:52 財經茄呢啡 線上醫療股回軟，阿里健康挫１１．３％，報１０．２元，為表現最差藍籌股；藥明生物跌１０．９８％，報１０１．３元，跌幅居第二位 ;平安好醫生挫１５．２７％，見５７．７元，最低見５６．８元；京東健康跌１１．８６％，報５９．８元 ; 藥明巨諾-Ｂ跌９．７６％，報１５．９元 ; 信達生物挫１１．９８％，報５９．１５元 ; 復星醫藥跌８．７９％，報４８．７５元 ; 康希諾生物-Ｂ跌７．４７％，報２６２．６元。
Alibaba Health Information Technology Limited 2021-08-13T14:49 財經茄呢啡 生物科技股：國務院印發《法治政府建設實施綱要》，提出將加大食品藥品等重點領域執法力度，其他生物科技股也受壓。百濟神州插６．７％；泰格插７．５％；康方瀉７．８％；藥明生物跌２．８％；隔晚美國兩大新冠疫苗股急瀉，香港上市的疫苗股也捱沽，康希諾插７．６％；持有科興股份的中生制藥，全日跌２．８％；另外，阿里健康挫４．４％，為表現最差藍籌；平安好醫生降２．１％。
Alibaba Health Information Technology Limited 2021-08-13T14:49 財經茄呢啡 藍籌股 ２３ 升 ３２ 跌 ３ 持平。利潤較預期為佳的創科實業 升逾 １１％，為升幅最大藍籌。其次是比亞迪 及吉利汽車 升逾 ３％ 及 ２％。中石油 升 ２％。中華煤氣 、電能實業 及長江基建 升逾 １％。阿里健康 、港交所 跌逾 ４％ 及 ３％，為跌幅最大藍籌。其次是中生制藥 及藥明生物 跌近 ３％。碧桂園服務 、華潤置地、中國平安 及友邦保險 跌逾 ２％。
Alibaba Health Information Technology Limited 2021-08-13T14:49 財經茄呢啡 藍籌股２３漲３２跌３持平，利潤高於預估的創科實業(ＨＫ０６６９)漲超１１％，是表現最佳藍籌。阿里健康(ＨＫ０２４１)、港交所(ＨＫ０３８８)跌超３％，是跌幅最大藍籌。
Alibaba Health Information Technology Limited 2021-08-13T14:49 財經茄呢啡 醫藥品行業再次被盯上，兩大醫藥平台股應聲下降，阿里健康急挫４．４％，收報１２．１８元，是最大幅回落幅藍籌；京東健康更重創７．４％，報７６．８元。兩者母公司股價也受到拖累，阿里巴巴低收１．３％，至１８８．７元；京東集團挫近２％，報２７６．２元。平安好醫生亦回軟２．１％，收報７２．９５元。
Alibaba Health Information Technology Limited 2021-08-13T14:49 財經茄呢啡 恆生科技指數跌１．２６％，百度以３．２１％跌幅墊底，同程藝龍跌２．６９％，阿里健康跌２．４６％，騰訊控股跌２．２４％，美團跌近２％，阿里巴巴與京東健康、網易跌約１．７％。
Alibaba Health Information Technology Limited 2021-08-06T14:48 財經茄呢啡 醫藥股今天亦處於弱勢，阿里健康收市報１１．８６元，跌６．７％，中生制藥跌０．７％，報６．８７元，石藥卻上漲，升０．４％，報１０．６４元。
Alibaba Health Information Technology Limited 2021-08-06T14:48 財經茄呢啡 藍籌股１２漲４５跌１持平，金沙中國(ＨＫ１９２８)和銀河娛樂(ＨＫ００２７)漲幅超過２％，是表現最佳藍籌。阿里健康(ＨＫ０２４１)和碧桂園服務(ＨＫ６０９８)跌超６％和４％，是跌幅最大藍籌。
Alibaba Health Information Technology Limited 2021-07-30T14:41 財經茄呢啡 恆指低開低走，截至午盤，恆指跌２．１％，報２５７６２．０２點，恆生科技指數暴跌４．２３％。科技股集體大挫，新東方在線跌超１０％，Ｂ站、快手、美團跌超８％，阿里跌超５％，騰訊跌４％。醫藥股集體大挫，再鼎醫藥跌超１１％，阿里健康跌超９％。消費股大挫，青島啤酒跌近８％。恆大系集體大挫，中國恆大挫１０％。東岳集團再次暴漲１４％。瑞信發研報指，認為東岳集團為新能源車供給鏈中的一只潛力股。
Alibaba Health Information Technology Limited 2021-07-30T14:41 財經茄呢啡 恆指周四(２９日) 升８４１點，報２６３１５點，大市全日成交２５４１．２２億元。騰訊勁彈１０％，報４９２元，成交居首達３５１．０８億元。成交第二大是美團，升９．５％，報２２８．４元。百威亞太第二季業績不及預期，收市跌３％，為表現最差藍籌。早前捱沽的阿里健康急升２２．７％，為今天表現最好藍籌。
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.